Crystallization technologies are bridges between drug substances (DS) and drug products (DP) enabling consistent and robust safety and efficacy profiles for small molecule-based medicines. In an effort to fully utilize existing tools and develop better methodologies for solving bottleneck problems, the second annual edition of the Pharmaceutical Crystallization Summit will gather top industrial and academic experts to discuss their work related to DS crystallization R&D and manufacturing, including: